-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Immunotherapy with Drugs

Program: Education Program
Session: Understanding How to Manipulate the Immune System in Immunotherapy for Lymphoma
Monday, December 7, 2020, 6:55 AM-7:00 AM

Catherine Diefenbach, MD

New York University School of Medicine, NYU Cancer Institute, New York, NY

Disclosures: Diefenbach: LAM Therapeutics: Research Funding; Incyte: Research Funding; Genentech, Inc.: Consultancy, Research Funding; Bristol-Myers Squibb: Consultancy, Research Funding; MEI: Research Funding; Denovo: Research Funding; Merck: Consultancy, Research Funding; Trillium: Research Funding; Millenium/Takeda: Research Funding; Seattle Genetics: Consultancy, Research Funding.